Anlon Healthcare Ltd

Thu 25/06/2026,15:56:38 | NSE : AHCL

₹16.290.16 (0.99%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 16.29

Previous Close

₹ 16.13

Volume

7009180

Mkt Cap ( Rs. Cr)

₹86.58

High

₹ 16.73

Low

₹ 16.21

52 Week High

₹ 17.28

52 Week Low

₹ 9.08

Book Value Per Share

₹ 35.32

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Anlon Healthcare Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

16.29

14779

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

14779

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anlon Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anlon Healthcare - Reply to Clarification- Financial results

    25 Jun 2026, 2:21PM The Exchange had sought clarification from Anlon Healthcare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listi

  • Anlon Healthcare - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Invitation For TV Interview On NDTV Prof

    11 Jun 2026, 11:12AM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Updates

    11 Jun 2026, 11:03AM Anlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Inte

  • Anlon Healthcare - Intimation Regarding Media Interaction Of Chairman & Managing Director

    9 Jun 2026, 6:33PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Updates

    9 Jun 2026, 6:28PM Anlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing Director.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Jun 2026, 11:18AM Anlon Healthcare Limited has informed the Exchange about Transcript

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    9 Jun 2026, 11:23AM We have attached herewith earning call transcript as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    3 Jun 2026, 7:21PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Jun 2026, 7:13PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Investor Presentation

    3 Jun 2026, 12:40PM Anlon Healthcare Limited has informed the Exchange about Investor Presentation

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    3 Jun 2026, 12:44PM We have attached herewith investor presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\

  • Anlon Healthcare - Press Release

    30 May 2026, 11:32AM Anlon Healthcare Limited has informed the Exchange regarding a press release dated May 29 2026, titled ""Intimation for Press release of Audited Finan

  • Anlon Healthcare - Copy of Newspaper Publication

    30 May 2026, 11:23AM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication dated 30th May, 2026 regarding publication of extract of Audite

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 May 2026, 11:37AM Intimation for Press Release of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31, 2026.

  • Anlon Healthcare - Considered, Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St Mar

    29 May 2026, 12:52PM We have attached herewith the Audited Financial Results (Standalone and Consolidated) together with the Report of the Auditor thereon.\r\n\r\nPlease t

  • Anlon Healthcare Q4 net profit down 41.20% at Rs 9.79 cr

    29 May 2026, 12:50PM The company reported standalone net profit of Rs 9.79 crore for the quarter ended March 31, 2026 as compared to Rs 16.65 crore in the same period last

  • Anlon Healthcare - Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 3

    29 May 2026, 12:23PM We have attached herewith outcome of Board Meeting held on Friday, May 29, 2026.\r\n\r\nKindly take the same on your record. \r\n\r\nThank you.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 May 2026, 7:09PM We have attached herewith Intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    28 May 2026, 7:06PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Res

    23 May 2026, 5:50PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and

  • Anlon Healthcare - Monitoring Agency Report

    13 May 2026, 1:42PM Monitoring Agency Report for the Quarter ended on March 31, 2026.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    13 May 2026, 1:50PM Monitoring Agency Report for the Quarter ended on March 31, 2026.

  • Anlon Healthcare - Updates On Acquisition

    8 May 2026, 2:22PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulations, 2015 regarding acquisition of stake in Remember India Health Lin

  • Anlon Healthcare - General Updates

    8 May 2026, 2:07PM Anlon Healthcare Limited has informed the Exchange about 'Disclosure dated April 16, 2026, regarding acquisition of stake in Remember India Health Lin

  • Anlon Healthcare - Disclosure under SEBI Takeover Regulations

    7 May 2026, 11:35AM Anlon Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subs

  • Anlon Healthcare - General Updates

    27 Apr 2026, 12:37PM Anlon Healthcare Limited has informed the Exchange about General Updates

  • Anlon Healthcare - Outcome of Board Meeting

    27 Apr 2026, 9:31AM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026, regarding allotment of Bonus equity shar

  • Anlon Healthcare - Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation

    27 Apr 2026, 12:41PM General Update

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Allotment

    27 Apr 2026, 9:35AM Bonus Equity Shares

  • Anlon Healthcare - Updates

    22 Apr 2026, 4:23PM Anlon Healthcare Limited has informed the Exchange regarding 'Intimation of New ISIN pursuant to Sub-division/Split of Equity Shares.'.

  • Anlon Healthcare - Intimation Of New ISIN

    22 Apr 2026, 4:31PM Intimation of New ISIN pursuant to Split/Sub Division of Equity Shares.

  • Anlon Healthcare - Agreements

    16 Apr 2026, 2:17PM Anlon Healthcare Limited has informed the Exchange about Agreements

  • Anlon Healthcare - Outcome of Board Meeting

    16 Apr 2026, 1:10PM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on April 16, 2026.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    16 Apr 2026, 2:22PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Priva

    16 Apr 2026, 1:19PM We have attached herewith outcome of Board Meeting held on Thursday, April 16, 2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Credit Rating- Others

    15 Apr 2026, 4:49PM Anlon Healthcare Limited has informed the Exchange about Credit Rating- Others

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Credit Rating

    15 Apr 2026, 4:52PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    15 Apr 2026, 4:41PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Anlon Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    11 Apr 2026, 2:11PM As of March 2026, 52.68% is owned by Indian Promoters and 47.32% by Public. <p align=justify> Institutional holds 4.92% (Insurance Companies 0.06%) an

  • Anlon Healthcare - Structural Digital Database

    11 Apr 2026, 11:59AM SDD Compliance certificate for the Quarter ended on March 31, 2026

  • Anlon Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Apr 2026, 11:57AM Anlon Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anlon Healthcare - Copy of Newspaper Publication

    10 Apr 2026, 12:46PM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    9 Apr 2026, 6:42PM We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015 for alteration of MOA.\r\n\r\nKindly take the same on your record.

  • Anlon Healthcare - Amendment to AOA/MOA

    9 Apr 2026, 6:40PM Anlon Healthcare Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

  • Anlon Healthcare - Record Date

    9 Apr 2026, 3:04PM Anlon Healthcare Limited has informed the Exchange that Record date for the purpose of Bonus & Split/Subdivision is 24-Apr-2026.

  • Anlon Healthcare - Corporate Action-Board recommends Bonus Issue

    9 Apr 2026, 3:11PM We have attached herewith intimation of Record date for the purpose of Bonus Issue.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Corporate Action-updates on Outcome of Sub division / Stock Split

    9 Apr 2026, 3:10PM We have attached herewith intimation of Record date for Split/Sub-division of Stock.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Shareholders meeting

    8 Apr 2026, 8:36PM Anlon Healthcare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regard

  • Anlon Healthcare - Disclosure under SEBI Takeover Regulations

    7 Apr 2026, 2:36PM Anlon Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subs
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anlon Healthcare Ltd stock 

Name March-26 March-25 March-24 March-23
Assets 255.372 138.7691 95.5946 73.761
Liabilities 255.372 138.7691 95.5946 73.761
Equity 53.1515 39.8515 16 12
Gross Profit 46.1378 32.2087 15.4611 12.4148
Net Profit 27.8082 20.5179 9.6571 5.82
Cash From Operating Activities -46.3581 -22.5517 -3.226 -2.8497
NPM(%) 15.75 17.05 14.5 5.15
Revenue 176.4987 120.2866 66.5837 112.8774
Expenses 130.3609 88.0779 51.1226 100.4626
ROE(%) 14.81 10.93 5.14 3.1

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anlon Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.20 -0.70 0.00 9.31 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 125.02 -2.37 4167.33 33.94 0.39 0.00
Vaishali Pharma Ltd 7.29 -0.95 23.52 212.91 15.96 0.00
Astec Lifesciences Ltd 725.45 -3.52 0.00 32.01 -363.14 0.00

Company Info

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Parent Organisation

Anlon Healthcare Ltd.

Founded

19/11/2013

Managing Director

Mr.Punitkumar R Rasadia

NSE Symbol

AHCLEQ

FAQ